Home/Filings/4/0001140361-23-022490
4//SEC Filing

Vollins James 4

Accession 0001140361-23-022490

CIK 0001305253other

Filed

May 1, 8:00 PM ET

Accepted

May 2, 4:30 PM ET

Size

5.1 KB

Accession

0001140361-23-022490

Insider Transaction Report

Form 4
Period: 2023-04-30
Vollins James
General Counsel
Transactions
  • Award

    Stock Option (Right to Buy)

    2023-04-30+120,000120,000 total
    Exercise: $1.03Exp: 2033-04-29Common Stock (120,000 underlying)
Footnotes (1)
  • [F1]The option vests as to twenty-five percent of the shares upon the one-year anniversary of April 12, 2023, and in 36 equal monthly installments thereafter, subject to Reporting Person's continuous service status as of each such date.

Documents

1 file

Issuer

Eiger BioPharmaceuticals, Inc.

CIK 0001305253

Entity typeother

Related Parties

1
  • filerCIK 0001757833

Filing Metadata

Form type
4
Filed
May 1, 8:00 PM ET
Accepted
May 2, 4:30 PM ET
Size
5.1 KB